Nghia H. Nguyen, Vincent Nguyen, Huy N. Trinh, Brian Lin, Mindie H

Slides:

Advertisements

Similar presentations

The Role of Psychosocial Care in Adapting to Health Care Reform

Advertisements

A Polymorphism in Interferon L3 Is an Independent Risk Factor for Development of Hepatocellular Carcinoma After Treatment of Hepatitis C Virus Infection

Abnormal Liver Tests and Fatty Liver on Ultrasound

Thrombocytopenia With Abnormal Liver Function Tests

Arpan Mohanty, Sebhat Erqou, Kathleen A

Incorrect Calculation and Inappropriate Interpretation: Accuracy of International Guidelines for Identifying Significant Fibrosis in e Antigen–Negative.

Noncardiac Chest Pain Clinical Gastroenterology and Hepatology

Chronic Hepatitis C Therapy: Changing the Rules of Duration

Nathalie Adda, Doug J. Bartels, Linda Gritz, Tara L

A Treatment Algorithm for the Management of Chronic Hepatitis B Virus Infection in the United States: 2008 Update Emmet B. Keeffe, Douglas T. Dieterich,

Mauricio Garcia-Saenz-de-Sicilia, MD, Andres Duarte-Rojo, MD, MS, DSC

Pichamol Jirapinyo, Christopher C. Thompson

Coordinating Care in Patients With Cirrhosis

Uchenna H. Iloeje, Hwai–I

Effectiveness of Hepatitis B Treatment in Clinical Practice

A Model to Determine 3-Month Mortality Risk in Patients With Acute-on-Chronic Hepatitis B Liver Failure Ming–Hua Zheng, Ke–Qing Shi, Yu–Chen Fan, Hai.

A Shocking Cystory Clinical Gastroenterology and Hepatology

Right Upper Quadrant Pain and a Normal Abdominal Ultrasound

Prevalence of Irritable Bowel Syndrome–type Symptoms in Patients With Celiac Disease: A Meta-analysis Anita Sainsbury, David S. Sanders, Alexander C.

A Sustained Viral Response Is Associated With Reduced Liver-Related Morbidity and Mortality in Patients With Hepatitis C Virus Amit G. Singal, Michael.

A 5-Year Prospective Observational Study of the Outcomes of International Treatment Guidelines for Crohn's Disease Garret Cullen, Denise Keegan, Hugh.

Fasiha Kanwal, MD, MSHS, Hashem B. El-Serag, MD, MPH

No Differences in Achieving Hepatitis C Virus Care Milestones Between Patients Identified by Birth Cohort or Risk-Based Screening Brianna L. Norton,

Virologic Response to Therapy Increases Health-Related Quality of Life for Patients With Chronic Hepatitis B Jeong Han Kim, So Young Kwon, Young Sok.

The Appendix May Protect Against Clostridium difficile Recurrence

Interpreting Hepatitis B Surface Antigen Levels: Useful Clinical Test or Just Another Confusing Assay? Brian J. McMahon, MD, Brenna C. Simons, PhD Clinical.

Endoscopic Therapy for Barrett's Esophagus

Validation of Hepascore, Compared With Simple Indices of Fibrosis, in Patients With Chronic Hepatitis C Virus Infection in United States Laren Becker,

Prevalence and Challenges of Liver Diseases in Patients With Chronic Hepatitis C Virus Infection Ira M. Jacobson, Gary L. Davis, Hashem El–Serag, Francesco.

Efficacy and Durability of Radiofrequency Ablation for Barrett's Esophagus: Systematic Review and Meta-analysis Eric S. Orman, Nan Li, Nicholas J. Shaheen

Severe Constipation Clinical Gastroenterology and Hepatology

Abnormal Liver Tests and Fatty Liver on Ultrasound

Chronic Hepatitis B Virus Carriers in the Immunotolerant Phase of Infection: Histologic Findings and Outcome Tony Andreani, Lawrence Serfaty, Djamila.

New Models of Gastroenterology Practice

Issue Highlights Clinical Gastroenterology and Hepatology

Dushyant Singh, Reetu Singh, Wendell K. Clarkston

Effect of Human Immunodeficiency Virus and Antiretrovirals on Outcomes of Hepatitis C: A Systematic Review From an Epidemiologic Perspective Jennifer.

David H. Bruining, William J. Sandborn

Histologic Changes in Liver Tissue From Patients With Chronic Hepatitis B and Minimal Increases in Levels of Alanine Aminotransferase: A Meta-analysis.

Chronic Hepatitis C Therapy: Changing the Rules of Duration

A Treatment Algorithm for the Management of Chronic Hepatitis B Virus Infection in the United States: 2008 Update Emmet B. Keeffe, Douglas T. Dieterich,

Brendan Campbell, Benny Liu, Taft Bhuket, Robert J. Wong

Peter Bytzer Clinical Gastroenterology and Hepatology

Rebecca M. Lovell, Alexander C. Ford

Patient-Reported Outcomes of Cirrhosis

Prevalence and Treatment of Hepatitis C Virus Genotypes 4, 5, and 6

Effects of Different Coping Strategies on Physical and Mental Health of Patients With Irritable Bowel Syndrome Lilian Dindo, PhD Clinical Gastroenterology.

Alan Bonder, MD, Nezam H. Afdhal, MD

Suna Yapali, MD, Anna S. Lok, MD, FRCP

Chronic Diarrhea Clinical Gastroenterology and Hepatology

Hepatic Cyst? Clinical Gastroenterology and Hepatology

Thrombocytopenia With Abnormal Liver Function Tests

Christos Konstantakis, Maria Karamesini, Christos Triantos

Predictors of Early Treatment Discontinuation Among Patients With Genotype 1 Hepatitis C and Implications for Viral Eradication Lauren A. Beste, George.

Hepatitis C Virus Infection, Age, and Hispanic Ethnicity Increase Mortality From Liver Cancer in the United States Zobair M. Younossi, Maria Stepanova

Geertrui Coppens, Jo Van Dorpe, Filip Baert

A 27-Year-Old Woman With Constipation: Diagnosis and Treatment

Management of Hepatitis B

Coagulation in Liver Disease: A Guide for the Clinician

Issue Highlights Clinical Gastroenterology and Hepatology

Issue Highlights Clinical Gastroenterology and Hepatology

Lauren B. Gerson, Peter J. Kahrilas, Ronnie Fass

Rintaro Hashimoto, Akimichi Chonan

Adverse Outcomes: Why Bad Things Happen to Good People

Medical Therapy for Refractory Pediatric Crohn’s Disease

An Unusual Case of Gastritis and Duodenitis After Yttrium 90–Microsphere Selective Internal Radiation Jessica Baumann, Mark Lin, Charmi Patel Clinical.

Rintaro Hashimoto, Akimichi Chonan

The Role of Psychosocial Care in Adapting to Health Care Reform

Fasiha Kanwal, Tuyen Hoang, Timothy Chrusciel, Jennifer R

Choosing Wisely and the Perceived Drivers of Endoscopy Use

Presentation transcript:

Treatment Eligibility of Patients With Chronic Hepatitis B Initially Ineligible for Therapy Nghia H. Nguyen, Vincent Nguyen, Huy N. Trinh, Brian Lin, Mindie H. Nguyen Clinical Gastroenterology and Hepatology Volume 11, Issue 5, Pages 565-571 (May 2013) DOI: 10.1016/j.cgh.2012.12.028 Copyright © 2013 AGA Institute Terms and Conditions

Figure 1 Flow diagram for patients presenting with CHB infection who were evaluated for treatment eligibility according to treatment guidelines. HCV, hepatitis C virus; HDV, hepatitis D virus. Clinical Gastroenterology and Hepatology 2013 11, 565-571DOI: (10.1016/j.cgh.2012.12.028) Copyright © 2013 AGA Institute Terms and Conditions

Figure 2 Treatment-naive patients at initial evaluation (n = 304). Clinical Gastroenterology and Hepatology 2013 11, 565-571DOI: (10.1016/j.cgh.2012.12.028) Copyright © 2013 AGA Institute Terms and Conditions

Figure 3 Patients who initially were treatment-ineligible who later became treatment-eligible according to treatment criteria. Clinical Gastroenterology and Hepatology 2013 11, 565-571DOI: (10.1016/j.cgh.2012.12.028) Copyright © 2013 AGA Institute Terms and Conditions